These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5346351)

  • 41. [Clinical and immunological prospective study of the measles live virus vaccine].
    Sujoy E; Blaksley JC; Shepherd G; Simsolo V; Palais L; Pizzia A; Becker D; Behar M; Morgenstern O
    Arch Argent Pediatr; 1966; 63(7):260-5. PubMed ID: 5990418
    [No Abstract]   [Full Text] [Related]  

  • 42. Antibody titres and protective efficacy two to four years after vaccination against measles.
    Watson GI; Parry JM
    Mon Bull Minist Health Public Health Lab Serv; 1967 Aug; 26():146-53. PubMed ID: 5630480
    [No Abstract]   [Full Text] [Related]  

  • 43. Measles vaccination of macaques by dry powder inhalation.
    de Swart RL; LiCalsi C; Quirk AV; van Amerongen G; Nodelman V; Alcock R; Yüksel S; Ward GH; Hardy JG; Vos H; Witham CL; Grainger CI; Kuiken T; Greenspan BJ; Gard TG; Osterhaus AD
    Vaccine; 2007 Jan; 25(7):1183-90. PubMed ID: 17084489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measles vaccination: new strategies and formulations.
    de Vries RD; Stittelaar KJ; Osterhaus AD; de Swart RL
    Expert Rev Vaccines; 2008 Oct; 7(8):1215-23. PubMed ID: 18844595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measles and measles vaccination in isolated Amerindian tribes. II. The 1978/79 Xingu epidemic.
    Baruzzi RG; Abdala N; Black FL
    Trop Geogr Med; 1982 Mar; 34(1):7-12. PubMed ID: 7080192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Vaccination against measles--adverse effects, cause of reduced protective effect in investigated material].
    Enell H; Simonsson H
    Lakartidningen; 1973 Sep; 70(39):3357-8. PubMed ID: 4788642
    [No Abstract]   [Full Text] [Related]  

  • 47. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
    Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
    Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on measles in Thailand. II. Field trials of measles vaccine, with special reference to the K-L method.
    Tsuchinda P; Jayavasu J; Sangkawibha N; Okuno Y; Ueda S
    Biken J; 1967 Sep; 10(3):135-41. PubMed ID: 6081222
    [No Abstract]   [Full Text] [Related]  

  • 49. Measles antibody response in vaccinated children.
    Evliyaoğlu N; Altintaş D; Kiliç NB; Alhan SE; Onenli N; Güneşer S; Bahçebaşi T
    Turk J Pediatr; 1996; 38(3):315-21. PubMed ID: 8827900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measles outbreak in western Sydney. Vaccine failure or failure to vaccinate?
    McDonnell LF; Jorm LR; Patel MS
    Med J Aust; 1995 May; 162(9):471-5. PubMed ID: 7746203
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [On the effect of combined measles vaccination].
    Ritzel G; Just M
    Schweiz Med Wochenschr; 1967 Apr; 97(13):405-6. PubMed ID: 5593611
    [No Abstract]   [Full Text] [Related]  

  • 52. Potency control of live, attenuated vaccines against measles used in children vaccinations in the State of São Paulo, Brazil [1976-1980].
    Pral MM; Woe Fang FL; de Rizzo E
    Rev Inst Med Trop Sao Paulo; 1982; 24(1):1-5. PubMed ID: 7123066
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial.
    Kohler KA; Suleiman AJ; Robertson SE; Malankar P; Al-Khusaiby S; Helfand RF; Brown D; Bellini WJ; Sutter RW
    J Infect Dis; 2003 May; 187 Suppl 1():S177-85. PubMed ID: 12721911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measles control: so near and yet so far.
    Mitchell CD; Balfour HH
    Prog Med Virol; 1985; 31():1-42. PubMed ID: 3881804
    [No Abstract]   [Full Text] [Related]  

  • 55. Measles vaccination. VII. Follow-up studies in children immunized with four doses of inactivated vaccine.
    Norrby E; Lagercantz R; Gard S
    Acta Paediatr Scand; 1969 May; 58(3):261-7. PubMed ID: 5783412
    [No Abstract]   [Full Text] [Related]  

  • 56. [Reasons to recommend measles vaccination in Sweden].
    Grubb R; Hedlund P; Lagercrantz R; Lundbäck H; Norrby E; Svedmyr A
    Lakartidningen; 1972 Feb; 69(7):702-4. PubMed ID: 5015717
    [No Abstract]   [Full Text] [Related]  

  • 57. Two-year follow-up study of measles vaccine antibodies.
    Med J Aust; 1970 Mar; 1(11):532-4. PubMed ID: 5443510
    [No Abstract]   [Full Text] [Related]  

  • 58. A field trial of further attenuated live measles virus vaccines in Japan, 1968.
    Jpn J Med Sci Biol; 1969 Aug; 22(4):191-200. PubMed ID: 4982563
    [No Abstract]   [Full Text] [Related]  

  • 59. A ten-year follow-up study on measles vaccination in Japan: evaluation of the efficacy analyzed on a computer system.
    Shishido A; Sugishita C; Takahashi C; Sakata H; Hirayama M; Kimura M
    Jpn J Med Sci Biol; 1978 Aug; 31(4):339-56. PubMed ID: 713161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody titres three years after immunization with a live measles vaccine.
    Schumacher H; Welbers de Liddle IB
    Ger Med Mon; 1971; 1(1):37-41. PubMed ID: 5579592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.